Troriluzole Fails First Phase III Test As Biohaven Looks Beyond Migraine

 
• By Mandy Jackson
  
Closed up finger on keyboard with word CLINICAL TRIALS
Troriluzole failed in anxiety, but has three other readouts in 2020 and 2021.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D